about
Molecular mechanisms for adaptive tolerance and other T cell anergy modelsMechanisms of Natural Tolerance in the IntestineTunable chemokine production by antigen presenting dendritic cells in response to changes in regulatory T cell frequency in mouse reactive lymph nodes.T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-gamma expression.Macrophage suppression of T cell activation: a potential mechanism of peripheral tolerance.Changes in function of antigen-specific lymphocytes correlating with progression towards diabetes in a transgenic model.Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetopeThe contributions of T-cell anergy to peripheral T-cell tolerance.Is Th1 the solution for Th2 in asthma?A two-step, two-signal model for the primary activation of precursor helper T cellsT-helper cell tolerance to ubiquitous nuclear antigensInduction of antigen-specific T cell anergy: An early event in the course of tumor progressionMultimerized T cell epitopes protect from experimental autoimmune diabetes by inducing dominant tolerance.Functional avidity directs T-cell fate in autoreactive CD4+ T cells.Peptide-based instruction of suppressor commitment in naïve T cells and dynamics of immunosuppression in vivo.CD4+ T cells that enter the draining lymph nodes after antigen injection participate in the primary response and become central-memory cellsTargeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes.The stimulation of low-affinity, nontolerized clones by heteroclitic antigen analogues causes the breaking of tolerance established to an immunodominant T cell epitope.Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivoCross-tolerance: a pathway for inducing tolerance to peripheral tissue antigensCD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cellsB cells directly tolerize CD8(+) T cells.A logical analysis of T cell activation and anergy.Too dangerous to ignore: self-tolerance and the control of ignorant autoreactive T cells.Regulatory function of in vivo anergized CD4(+) T cellsTowards identification of the mechanisms of action of parasite-derived peptide GK1 on the immunogenicity of an influenza vaccineDepletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis.Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.Induction of immunologic tolerance for transplantation.Long-term persistence of IL-2-unresponsive allogeneic T cells in sublethally irradiated SCID mice.Paralysis of B7 co-stimulation through the effect of viral IL-10 on T cells as a mechanism of local tolerance induction.Dynamics of suppressor T cells: in vivo veritas.CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation.Th2 polarization enhanced by oral administration of higher doses of antigen.A specific signalling signature characterizes the development of naturally occurring and antigen-specific regulatory T cells.Lymphocyte Activation Gene 3 (LAG-3) modulates the ability of CD4 T-cells to be suppressed in vivo.The anergy induction of M3 muscarinic acetylcholine receptor-reactive CD4+ T cells suppresses experimental sialadenitis-like Sjögren's syndrome.
P2860
Q24671646-91D6959D-B62F-4FF6-B791-0B2367170760Q29031968-3A51D063-798C-4400-AF92-61F6E226D465Q33515288-BDDD048A-6930-4AB6-AC0C-C4A7B651308EQ33756668-A4BFDBF6-BA0F-4E40-99C4-FDBBD1EB61E7Q33836332-CB33415A-A756-4F8C-AD97-BD42F0AE19D8Q33887966-767B123E-AA48-4BC4-AFF7-EE86D30B85E9Q33937758-8823A5E6-4DE3-4FC2-B80D-2365161A70DCQ34308870-FD7DAFD1-ADFB-42C6-B7A3-06987DAD4BE2Q34632441-65B3E3C4-5874-4A75-A73A-C18ACE4F6EE0Q34797521-F2E2E0E2-D09D-4017-8A02-51A2B0C31288Q35589560-F67CC0F3-6057-40AC-B371-A90D538FE5A9Q35798927-9987D323-7B9D-4C7D-B856-265571C5C42BQ35839611-361BE14E-F68F-4BE1-AD0B-32000128BA6AQ35848366-8D65BD7D-03D4-422E-A18C-BB6299AB4CA8Q36161507-25EDA8E1-B3FD-4E34-91FE-F75EFDBE7784Q36228572-EDD20FBD-DBE2-4853-8FB8-B23B403F5750Q36310443-5EE9592D-29C5-4194-91F7-07343FCC8734Q36375353-C6436DB4-F508-4946-8C16-7EB9EF3D9DD0Q36400127-D947DC5E-8509-4281-BB59-C7196D535469Q36400803-A52A04CE-0D5B-4EA6-A8B8-7D178F6ABBF5Q36400881-497BEC3B-4AB3-4716-8515-B48D86FCEC81Q36401188-24FE9DA8-74E1-4A4F-809C-8617B8CF2179Q36454568-F2A43039-12DF-4A81-926D-A2833B725B77Q37070256-23D9685C-679F-47C3-8E79-84507132D626Q37113443-CD32621F-BCD3-4DD8-893A-5E5AC1F1FD97Q37349250-51306AD6-5BCE-4AD7-B038-F90640262F48Q37690014-6480C3AB-844E-4E97-B9A2-D6327BDDD2E0Q39601191-88AB0A2A-8319-4402-A02C-6B757749EE77Q40827011-EBE91353-82C3-4800-BD6B-F9B59DCA18DFQ40925507-EA6EBF93-A252-4898-9799-81E2C50D7822Q40990067-17E2E9F9-8CCD-4A52-A6F0-CEB2691C0FA6Q41860405-1EE8F325-BB21-4EB3-9162-DC69CA9F5A29Q42082972-89EC1CF4-67E7-4FFC-9425-5C5A46CA0C7CQ42110155-4A8064CB-9AAE-4E77-9904-4BA15C0859C9Q42461939-7AF24077-C9A7-4478-8900-C490FAF2C2DCQ42976150-AF244B42-865C-497A-A96F-A63861456FF0Q50987029-8954B251-A106-4734-9A94-481642D60FB0
P2860
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Conditions that induce tolerance in mature CD4+ T cells
@ast
Conditions that induce tolerance in mature CD4+ T cells
@en
type
label
Conditions that induce tolerance in mature CD4+ T cells
@ast
Conditions that induce tolerance in mature CD4+ T cells
@en
prefLabel
Conditions that induce tolerance in mature CD4+ T cells
@ast
Conditions that induce tolerance in mature CD4+ T cells
@en
P2093
P2860
P356
P1476
Conditions that induce tolerance in mature CD4+ T cells
@en
P2093
P2860
P304
P356
10.1084/JEM.185.3.405
P407
P577
1997-02-01T00:00:00Z